Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison- An Analysis Based on All Pivotal Phase 3 Clinical Trial Data
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2959
https://www.valueinhealthjournal.com/article/S1098-3015(17)33293-X/fulltext
Title :
Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison- An Analysis Based on All Pivotal Phase 3 Clinical Trial Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33293-X&doi=10.1016/j.jval.2017.08.2959
First page :
A935
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2705